Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-kappa B Signaling Pathway
Hits:
|
|
Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-kappa B Signaling Pathway
Hits:
|
|